Susanne Arnold

Academic / Other · 11 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Novel Agents for Treatment of High-risk COVID-19 Positive Patients COVID, Sars-CoV2	Phase 2	2020-05-01
Active Not Recruiting	Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers Carcinoma, Squamous Cell, Head and Neck Cancer	Phase 2	2017-04-11
Completed	A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN Head and Neck Cancer, Larynx	Phase 2	2014-10-01
Withdrawn	A Protocol of Irinotecan for Carcinoma of the Lung Lung Cancer	Phase 2	2013-10-01
Completed	Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens Lung Cancer	—	2011-09-01
Terminated	Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Nec Head and Neck Cancer	Phase 1	2005-12-01
Completed	Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer Stage IV Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer	Phase 2	2005-08-01
Completed	Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning Lung Cancer	N/A	2004-11-01
Terminated	Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSC Non-Small Cell Lung Cancer	Phase 1	2004-11-01
Completed	Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer Squamous Cell Carcinoma	Phase 2	2002-09-01
Completed	Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer Squamous Cell Carcinoma	Phase 2	2000-05-01